BioXcel Therapeutics, Inc. earnings per share and revenue

BTAI earnings per share for the last quarter are -0.76 USD whereas the estimation was -0.92 USD which accounts for 17.09% surprise. Company revenue for the same period amounts to 376.00 k USD despite the estimated figure of 742.86 k USD. Estimated earnings per share for the next quarter are -0.70 USD, and revenue is expected to reach 433.33 k USD. Also watch annual changes over time to get a bigger picture of BTAI earnings per share and revenue dynamics.